ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,866,080 | +101.8% | 16,000 | +60.0% | 0.15% | +119.4% |
| Q2 2023 | $3,897,300 | +22.7% | 10,000 | +11.1% | 0.07% | -10.7% |
| Q3 2022 | $3,177,000 | -51.3% | 8,998 | -47.7% | 0.08% | -56.4% |
| Q2 2022 | $6,519,000 | +62.3% | 17,207 | +50.0% | 0.17% | +115.0% |
| Q4 2021 | $4,017,000 | +164.8% | 11,471 | -42.6% | 0.08% | +142.4% |
| Q3 2018 | $1,517,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |